Subjective well being of schizophrenic patients in Greece - AURA
Study identifier:NIS-NGR-DUM-2008/2
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Subjective well being of schizophrenic patients in Greece
Medical condition
schizophrenia
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
600
Study type
Observational
Age
18 Years - 65 Years
Date
Study Start Date: 01 Mar 2009
Primary Completion Date: 01 Oct 2009
Study Completion Date: 01 Oct 2009
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Dec 2010 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
Contacts
Investigators
Principal Investigator
Errikos Tzempelikos
Sismanoglio Hospital, Psychiatric Department, Greece
